Acitretin
- Generic Name
- Acitretin
- Brand Names
- Soriatane
- Drug Type
- Small Molecule
- Chemical Formula
- C21H26O3
- CAS Number
- 55079-83-9
- Unique Ingredient Identifier
- LCH760E9T7
Overview
An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate.
Background
An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate.
Indication
For the treatment of severe psoriasis in adults.
Associated Conditions
- Keratinization disorders
- Severe Psoriasis
Clinical Trials
FDA Approved Products
Acitretin
Manufacturer:Amneal Pharmaceuticals of New York LLC
Route:ORAL
Strength:25 mg in 1 1
Approved: 2023/12/30
NDC:0115-1753
ACITRETIN
Manufacturer:Sigmapharm Laboratories, LLC
Route:ORAL
Strength:10 mg in 1 1
Approved: 2023/01/10
NDC:42794-080
Acitretin
Manufacturer:Amneal Pharmaceuticals of New York LLC
Route:ORAL
Strength:22.5 mg in 1 1
Approved: 2023/12/30
NDC:0115-1752
Acitretin
Manufacturer:Amneal Pharmaceuticals of New York LLC
Route:ORAL
Strength:17.5 mg in 1 1
Approved: 2023/12/30
NDC:0115-1751
ACITRETIN
Manufacturer:AvKARE
Route:ORAL
Strength:10 mg in 1 1
Approved: 2024/01/09
NDC:42291-086
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath